Results 201 to 210 of about 59,126 (309)
Sex differences in heart failure (HF) management and outcomes in the French‐DataHF cohort. CI, confidence interval; HFH, heart failure hospitalization; HR, hazard ratio; IPW, inverse probability weighting; KM, Kaplan–Meier; LD, loop diuretic; RAS, renin–angiotensin system; RASi, renin–angiotensin system inhibitor.
Guillaume Baudry +7 more
wiley +1 more source
The Effect of Mineralocorticoid Receptor Antagonists on Heart Failure with Nonreduced Ejection Fraction: A Systematic Review and Meta-Analysis. [PDF]
De Luca C +10 more
europepmc +1 more source
Selection of a mineralocorticoid receptor antagonist for patients with hypertension or heart failure [PDF]
Javaid Iqbal +5 more
openalex +1 more source
Abstract Aims Intravenous iron has emerged as a guideline‐recommended therapy in patients with heart failure and iron deficiency, but the potential sex‐related differences in efficacy are unknown. We aimed to assess sex‐specific outcomes in the Intravenous Iron in Patients with Systolic Heart Failure and Iron Deficiency to Improve Morbidity & Mortality
Mahir Karakas +49 more
wiley +1 more source
Aldosterone Breakthrough for the Prediction of Treatment Response to Mineralocorticoid Receptor Antagonists. [PDF]
Imcaoudene AR +5 more
europepmc +1 more source
Design and synthesis of aryl sulfonamide-based nonsteroidal mineralocorticoid receptor antagonists
Kentaro Futatsugi +8 more
openalex +1 more source
Computational modelling of myocardial metabolism in patients with advanced heart failure
LV, left ventricular; LVAD, left ventricular assist device; LVEF, left ventricular ejection fraction. Abstract Aims Perturbations of myocardial metabolism and energy depletion are well‐established hallmarks of heart failure (HF), yet methods for their systematic assessment remain limited in humans.
Niklas Beyhoff +17 more
wiley +1 more source

